Return to Article Details EVALUATION OF SERUM VISFATIN AS A NOVEL BIOMARKER IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS CORRELATION WITH LIVER ENZYMES Download Download PDF